Shanghai C&D INNOSTIC Medical Technology Group Co Ltd
SZSE:301584
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Shanghai C&D INNOSTIC Medical Technology Group Co Ltd (301584) under the Base Case is 31.6 CNY per share.
Compared with the current market price of 18.9 CNY, the stock appears
Undervalued by 40% .
The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 1.4% last year to 2.9% by 2031, higher than in any of the last three years. Revenue grows about 8% a year over the next five years.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Shanghai C&D INNOSTIC Medical Technology Group Does
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. engages in the direct sales and distribution of medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 2,115 full-time employees. The company went IPO on 2025-09-25. The firm primary sale products include vascular interventional devices, surgical instruments, testing reagents, and medical equipment. The firm also provides intensive medical consumables operations services, including consumables management and logistics distribution. The firm mainly conducts businesses within the domestic market.
- Headquarters
- China CN
- Employees
- 2 115
- IPO date
- Sep 25, 2025
Revenue & Expenses Breakdown
Shanghai C&D INNOSTIC Medical Technology Group Co Ltd
Earnings Waterfall
Shanghai C&D INNOSTIC Medical Technology Group Co Ltd
What is the Intrinsic Value of one Shanghai C&D INNOSTIC Medical Technology Group Co Ltd stock?
The intrinsic value for Shanghai C&D INNOSTIC Medical Technology Group Co Ltd (301584) under the Base Case is 31.6 CNY.
Is Shanghai C&D INNOSTIC Medical Technology Group Co Ltd stock undervalued or overvalued?
Compared with the current market price of 18.9 CNY, the stock appears Undervalued by 40% .
